Skip to main content
Log in

Two-year follow-up of one-stage left unilateral thoracoscopic epicardial and transcatheter endocardial ablation for persistent and long-standing persistent atrial fibrillation

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

A Correction to this article was published on 17 January 2020

This article has been updated

Abstract

Purpose

The purpose of this study was to analyze the efficacy and complication rates of a one-stage left unilateral thoracoscopic hybrid procedure in a series of patients with persistent and long-standing persistent atrial fibrillation (AF) in a 2-year follow-up.

Methods

Fifty-one consecutive patients (34 males, 65.7 ± 8 years) having undergone hybrid isolation of pulmonary veins (PVs) and posterior wall of left atrium (LA) by means of left unilateral hybrid thoracoscopic ablation for symptomatic persistent (n = 22, 43%) and long-standing persistent atrial fibrillation (AF) (n = 29, 57%) were analyzed.

Results

At a mean follow-up of 24.9 ± 11.8 months (median 24), the success rate without antiarrhythmic therapy was achieved in 68.6% of patients. Procedure-related major complications were observed in 2 patients (4%) including diaphragmatic perforation and late pericardial tamponade requiring mini left-sided thoracotomy and pericardial drainage, respectively. The success rate did not significantly differ between persistent and long-standing persistent AF (respectively, 68.2 and 69%; P = 0.89). Patients with AF relapse during the blanking period were 3.8 times more likely to have AF recurrence after 3 months from the ablation procedure.

Conclusion

The hybrid one-stage left unilateral thoracoscopic procedure exhibits encouraging results in the setting of both persistent and long-standing persistent AF after a 2-year follow-up, at a low rate of adverse events.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Change history

  • 17 January 2020

    Owing to a type error during final correction and proof data submission to the journal, there were mistakes introduced into the legends of Fig. 3 and Fig. 4 as well as into the Y-axis title of the plot of Fig. 4.

References

  1. Lee G, Sanders P, Kalman JM. Catheter ablation of atrial arrhythmias: state of the art. Lancet (London, England). 2012;380(9852):1509–19. https://doi.org/10.1016/S0140-6736(12)61463-9.

    Article  Google Scholar 

  2. Kirchhof P, Calkins H. Catheter ablation in patients with persistent atrial fibrillation. Eur Heart J. 2017;38(1):20–6. https://doi.org/10.1093/eurheartj/ehw260.

    Article  PubMed  Google Scholar 

  3. Weimar T, Schena S, Bailey MS, Maniar HS, Schuessler RB, Cox JL, et al. The Cox-Maze procedure for lone atrial fibrillation: a single-center experience over 2 decades. Circ Arrhythm Electrophysiol. 2012;5(1):8–14. https://doi.org/10.1161/CIRCEP.111.963819.

    Article  PubMed  Google Scholar 

  4. La Meir M, Gelsomino S, Lucà F, Pison L, Colella A, Lorusso R, et al. Minimal invasive surgery for atrial fibrillation: an updated review. Europace. 2013;15(2):170–82. https://doi.org/10.1093/europace/eus216.

    Article  PubMed  Google Scholar 

  5. Gaynor SL, Diodato MD, Prasad SM, Ishii Y, Schuessler RB, Bailey MS, et al. A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation. J Thorac Cardiovasc Surg. 2004;128(4):535–42. https://doi.org/10.1016/j.jtcvs.2004.02.044.

    Article  PubMed  Google Scholar 

  6. Wolf RK, Schneeberger EW, Osterday R, Miller D, Merrill W, Flege JB, et al. Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. J Thorac Cardiovasc Surg. 2005;130(3):797–802. https://doi.org/10.1016/j.jtcvs.2005.03.041.

    Article  PubMed  Google Scholar 

  7. Calkins H, Kuck K-H, Cappato R, Brugada J, Camm AJ, Chen S-A, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012;14(4):528–606. https://doi.org/10.1093/europace/eus027.

    Article  PubMed  Google Scholar 

  8. Calkins H, Hindricks G, Cappato R, Kim Y-H, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2018;20(1):e1–e160. https://doi.org/10.1093/europace/eux274.

    Article  PubMed  Google Scholar 

  9. de Asmundis C, Chierchia GB, Mugnai G, Van Loo I, Nijs J, Czapla J, et al. Midterm clinical outcomes of concomitant thoracoscopic epicardial and transcatheter endocardial ablation for persistent and long-standing persistent atrial fibrillation: a single-centre experience. Europace. 2017;19(1):58–65. https://doi.org/10.1093/europace/euw026.

    Article  PubMed  Google Scholar 

  10. Pison L, La Meir M, van Opstal J, Blaauw Y, Maessen J, Crijns HJ. Hybrid thoracoscopic surgical and transvenous catheter ablation of atrial fibrillation. J Am Coll Cardiol. 2012;60(1):54–61. https://doi.org/10.1016/j.jacc.2011.12.055.

    Article  PubMed  Google Scholar 

  11. Moritz A, Irouschek A, Birkholz T, Prottengeier J, Sirbu H, Schmidt J. The EZ-blocker for one-lung ventilation in patients undergoing thoracic surgery: clinical applications and experience in 100 cases in a routine clinical setting. J Cardiothorac Surg. 2018;13(1):77. https://doi.org/10.1186/s13019-018-0767-9.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Pak H-N, Hwang C, Lim HE, Kim JS, Kim Y-H. Hybrid epicardial and endocardial ablation of persistent or permanent atrial fibrillation: a new approach for difficult cases. J Cardiovasc Electrophysiol. 2007;18(9):917–23. https://doi.org/10.1111/j.1540-8167.2007.00882.x.

    Article  PubMed  Google Scholar 

  13. Mahapatra S, LaPar DJ, Kamath S, Payne J, Bilchick KC, Mangrum JM, et al. Initial experience of sequential surgical epicardial-catheter endocardial ablation for persistent and long-standing persistent atrial fibrillation with long-term follow-up. Ann Thorac Surg. 2011;91(6):1890–8. https://doi.org/10.1016/j.athoracsur.2011.02.045.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kurfirst V, Mokraček A, Bulava A, Čanadyova J, Haniš J, Pešl L. Two-staged hybrid treatment of persistent atrial fibrillation: short-term single-centre results. Interact Cardiovasc Thorac Surg. 2014;18(4):451–6. https://doi.org/10.1093/icvts/ivt538.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Muneretto C, Bisleri G, Bontempi L, Curnis A. Durable staged hybrid ablation with thoracoscopic and percutaneous approach for treatment of long-standing atrial fibrillation: a 30-month assessment with continuous monitoring. J Thorac Cardiovasc Surg. 2012;144(6):1460–5, discussion 1465. https://doi.org/10.1016/j.jtcvs.2012.08.069.

    Article  PubMed  Google Scholar 

  16. Muneretto C, Bisleri G, Rosati F, Krakor R, Giroletti L, Di Bacco L, et al. European prospective multicentre study of hybrid thoracoscopic and transcatheter ablation of persistent atrial fibrillation: the HISTORIC-AF trial. Eur J Cardio Thorac Surg. 2017;52(4):740–5. https://doi.org/10.1093/ejcts/ezx162.

    Article  Google Scholar 

  17. Budera P, Osmancik P, Talavera D, Kraupnerova A, Fojt R, Zdarska J, et al. Two-staged hybrid ablation of non-paroxysmal atrial fibrillation: clinical outcomes and functional improvements after 1 year. Interact Cardiovasc Thorac Surg. 2018;26(1):77–83. https://doi.org/10.1093/icvts/ivx248.

    Article  PubMed  Google Scholar 

  18. Zembala M, Filipiak K, Kowalski O, Buchta P, Niklewski T, Nadziakiewicz P, et al. Staged hybrid ablation for persistent and longstanding persistent atrial fibrillation effectively restores sinus rhythm in long-term observation. Arch Med Sci. 2017;13(1):109–17. https://doi.org/10.5114/aoms.2015.53960.

    Article  PubMed  Google Scholar 

  19. Maesen B, Pison L, Vroomen M, Luermans JG, Vernooy K, Maessen JG, et al. Three-year follow-up of hybrid ablation for atrial fibrillation. Eur J Cardio Thorac Surg. 2018;53(suppl_1):i26–32. https://doi.org/10.1093/ejcts/ezy117.

    Article  Google Scholar 

  20. Gehi AK, Mounsey JP, Pursell I, Landers M, Boyce K, Chung EH, et al. Hybrid epicardial-endocardial ablation using a pericardioscopic technique for the treatment of atrial fibrillation. Heart Rhythm. 2013;10(1):22–8. https://doi.org/10.1016/j.hrthm.2012.08.044.

    Article  PubMed  Google Scholar 

  21. Boersma LVA, Castella M, van Boven W, Berruezo A, Yilmaz A, Nadal M, et al. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation. 2012;125(1):23–30. https://doi.org/10.1161/CIRCULATIONAHA.111.074047.

    Article  PubMed  Google Scholar 

  22. Kress DC, Erickson L, Choudhuri I, Zilinski J, Mengesha T, Krum D, et al. Comparative effectiveness of hybrid ablation versus endocardial catheter ablation alone in patients with persistent atrial fibrillation. JACC Clin Electrophysiol. 2017;3(4):341–9. https://doi.org/10.1016/j.jacep.2016.10.010.

    Article  PubMed  Google Scholar 

  23. Pison L, Gelsomino S, Lucà F, Parise O, Maessen JG, Crijns HJGM, et al. Effectiveness and safety of simultaneous hybrid thoracoscopic and endocardial catheter ablation of lone atrial fibrillation. Ann Cardiothorac Surg. 2014;3(1):38–44. https://doi.org/10.3978/j.issn.2225-319X.2013.12.10.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Dzeshka MS, Lip GYH, Snezhitskiy V, Shantsila E. Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications. J Am Coll Cardiol. 2015;66(8):943–59. https://doi.org/10.1016/j.jacc.2015.06.1313.

    Article  PubMed  Google Scholar 

  25. Velagic V, de Asmundis C, Mugnai G, Irfan G, Hunuk B, Ströker E, et al. Repeat procedures after hybrid thoracoscopic ablation in the setting of longstanding persistent atrial fibrillation: electrophysiological findings and 2-year clinical outcome. J Cardiovasc Electrophysiol. 2016;27(1):41–50. https://doi.org/10.1111/jce.12837.

    Article  PubMed  Google Scholar 

  26. Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Mohanty S, Horton R, et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation. 2010;122(2):109–18. https://doi.org/10.1161/CIRCULATIONAHA.109.928903.

    Article  PubMed  Google Scholar 

  27. Di Biase L, Burkhardt JD, Mohanty P, Mohanty S, Sanchez JE, Trivedi C, et al. Left atrial appendage isolation in patients with longstanding persistent AF undergoing catheter ablation: BELIEF trial. J Am Coll Cardiol. 2016;68(18):1929–40. https://doi.org/10.1016/j.jacc.2016.07.770.

    Article  PubMed  Google Scholar 

  28. Pearman CM, Poon SS, Bonnett LJ, Haldar S, Wong T, Mediratta N, et al. Minimally invasive epicardial surgical ablation alone versus hybrid ablation for atrial fibrillation: a systematic review and meta-analysis. Arrhythmia Electrophysiol Rev. 2017;6(4):202–9. https://doi.org/10.15420/aer/2017.29.2.

    Article  Google Scholar 

  29. Je HG, Shuman DJ, Ad N. A systematic review of minimally invasive surgical treatment for atrial fibrillation: a comparison of the Cox-Maze procedure, beating-heart epicardial ablation, and the hybrid procedure on safety and efficacy. Europace. 2015;48(4):531–40, discussion 540–1. https://doi.org/10.1093/ejcts/ezu536.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carlo de Asmundis.

Ethics declarations

Conflict of interest

CdA receives compensation for teaching purposes and proctoring from AF Solutions, Medtronic, Abbott, Biotronik, and Atricure, and research grants on behalf of the center from Biotronik, Medtronic, St Jude Medical Abbot, Livanova, Boston Scientific, Biosense Webster, Atricure, and CardioTek. GBC receives compensation for teaching purposes and proctoring from AF Solutions and Medtronic. PB receives and speakers fees from Biotronik and Medtronic. MLM is a consultant for Atricure.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Asmundis, C., Varnavas, V., Sieira, J. et al. Two-year follow-up of one-stage left unilateral thoracoscopic epicardial and transcatheter endocardial ablation for persistent and long-standing persistent atrial fibrillation. J Interv Card Electrophysiol 58, 333–343 (2020). https://doi.org/10.1007/s10840-019-00616-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-019-00616-w

Keywords

Navigation